Skip to main content

At-Home Smell Test Can Help ID Risk for Cognitive Impairment

Medically reviewed by Carmen Pope, BPharm. Last updated on April 2, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, April 2, 2025 -- The digital remote AROMHA Brain Health Test (ABHT) can discriminate cognitively normal (CN) older adults from those with cognitive impairment, according to a study published online March 24 in Scientific Reports.

Benoît Jobin, Ph.D., from Massachusetts General Hospital in Boston, and colleagues developed the ABHT, an at-home odor identification, discrimination, memory, and intensity assessment, which was self-administered among 127 CN individuals (English and Spanish speaking), 34 participants with subjective cognitive complaints (SCC), and 19 participants with mild cognitive impairment (MCI). The test was self-administered remotely at home under unobserved (CN participants) and observed (CN, SCC, and MCI) modalities and in-person with a research assistant present (CN, SCC, and MCI).

The researchers found that with age, there was a decrease in odor memory, identification, and discrimination scores. In addition, compared with the CN and SCC groups, the MCI group had lower olfactory identification and discrimination, independent of age, sex, and education.

"These results suggest that the ABHT could be used in clinical research settings in different languages to explore the utility of olfactory biomarkers to predict the presence of blood-based, image-based, or cerebrospinal fluid-based biomarkers of neurodegenerative disease and longitudinal development of clinical symptoms," the authors write.

Several authors disclosed financial ties to Aromha.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Risk Factors for Alzheimer Disease Linked to Cognitive Function Before Midlife

THURSDAY, May 1, 2025 -- Risk factors for Alzheimer disease are associated with cognitive function starting in the mid-20s, according to a study published in the May issue of The...

Development of Severe Impairment Common in Long-Term Care Residents

THURSDAY, May 1, 2025 -- Development of severe permanent cognitive or functional impairment is common among residents admitted to long-term care (LTC), according to a study...

Exercise Helps Reduce Side Effects From Cancer Treatment

THURSDAY, May 1, 2025 -- Exercise mitigates adverse outcomes associated with cancer and its treatments, according to a review published online April 29 in the British Journal...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.